BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 22144400)

  • 21. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.
    Sutton CE; Lalor SJ; Sweeney CM; Brereton CF; Lavelle EC; Mills KH
    Immunity; 2009 Aug; 31(2):331-41. PubMed ID: 19682929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis.
    Blaschke S; Viereck V; Schwarz G; Klinger HM; Guerluek S; Müller GA
    Scand J Rheumatol; 2009; 38(4):235-9. PubMed ID: 19247848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease.
    Chi W; Yang P; Li B; Wu C; Jin H; Zhu X; Chen L; Zhou H; Huang X; Kijlstra A
    J Allergy Clin Immunol; 2007 May; 119(5):1218-24. PubMed ID: 17335887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gamma delta + T cells from patients with psoriatic and rheumatoid arthritis respond to streptococcal antigen.
    Grinlinton FM; Skinner MA; Birchall NM; Tan PL
    J Rheumatol; 1993 Jun; 20(6):982-7. PubMed ID: 8350335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.
    Hartgring SA; van Roon JA; Wenting-van Wijk M; Jacobs KM; Jahangier ZN; Willis CR; Bijlsma JW; Lafeber FP
    Arthritis Rheum; 2009 Sep; 60(9):2595-605. PubMed ID: 19714586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-17 accelerates allograft rejection by suppressing regulatory T cell expansion.
    Itoh S; Kimura N; Axtell RC; Velotta JB; Gong Y; Wang X; Kajiwara N; Nambu A; Shimura E; Adachi H; Iwakura Y; Saito H; Okumura K; Sudo K; Steinman L; Robbins RC; Nakae S; Fischbein MP
    Circulation; 2011 Sep; 124(11 Suppl):S187-96. PubMed ID: 21911812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synovial and peripheral blood CD4+FoxP3+ T cells in spondyloarthritis.
    Appel H; Wu P; Scheer R; Kedor C; Sawitzki B; Thiel A; Radbruch A; Sieper J; Syrbe U
    J Rheumatol; 2011 Nov; 38(11):2445-51. PubMed ID: 21921098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of CD146 expression to secretion of interleukin (IL)-17, IL-22 and interferon-γ by CD4(+) T cells in patients with inflammatory arthritis.
    Wu C; Goodall JC; Busch R; Gaston JS
    Clin Exp Immunol; 2015 Mar; 179(3):378-91. PubMed ID: 25113810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18.
    Tomura M; Maruo S; Mu J; Zhou XY; Ahn HJ; Hamaoka T; Okamura H; Nakanishi K; Clark S; Kurimoto M; Fujiwara H
    J Immunol; 1998 Apr; 160(8):3759-65. PubMed ID: 9558078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometric detection of type 1 (IL-2, IFN-gamma) and type 2 (IL-4, IL-5) cytokines in T-helper and T-suppressor/cytotoxic cells in rheumatoid arthritis, allergic asthma and atopic dermatitis.
    Schuerwegh AJ; De Clerck LS; De Schutter L; Bridts CH; Verbruggen A; Stevens WJ
    Cytokine; 1999 Oct; 11(10):783-8. PubMed ID: 10525317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased CCR4 expression on circulating CD4(+) T cells in ankylosing spondylitis, rheumatoid arthritis and systemic lupus erythematosus.
    Yang PT; Kasai H; Zhao LJ; Xiao WG; Tanabe F; Ito M
    Clin Exp Immunol; 2004 Nov; 138(2):342-7. PubMed ID: 15498047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory IL4+CD8+ T cells in patients with ankylosing spondylitis and healthy controls.
    Zhang L; Jarvis LB; Baek HJ; Gaston JS
    Ann Rheum Dis; 2009 Aug; 68(8):1345-51. PubMed ID: 18647857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of IL-18 receptor in cancer patients: its clinical significance.
    Kobashi K; Iwagaki H; Yoshino T; Morimoto Y; Kohka H; Kodama M; Nishibori M; Akagi T; Tanaka N
    Anticancer Res; 2001; 21(5):3285-93. PubMed ID: 11848485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer.
    Nagamine I; Yamaguchi Y; Ohara M; Ikeda T; Okada M
    Hiroshima J Med Sci; 2009 Mar; 58(1):37-44. PubMed ID: 19400555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type 1 and type 2 cytokine-producing CD4+ and CD8+ T cells in primary antiphospholipid syndrome.
    Karakantza M; Theodorou GL; Meimaris N; Mouzaki A; John E; Andonopoulos AP; Maniatis A
    Ann Hematol; 2004 Nov; 83(11):704-11. PubMed ID: 15300407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracytoplasmic cytokine expression and T cell subset distribution in the peripheral blood of patients with ankylosing spondylitis.
    Szántó S; Aleksza M; Mihály E; Lakos G; Szabó Z; Végvári A; Sipka S; Szekanecz Z
    J Rheumatol; 2008 Dec; 35(12):2372-5. PubMed ID: 19004035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor-alpha blockade leads to decreased peripheral T cell reactivity and increased dendritic cell number in peripheral blood of patients with ankylosing spondylitis.
    Pang L; Wang L; Suo T; Hao H; Fang X; Jia J; Huang F; Tang J
    J Rheumatol; 2008 Nov; 35(11):2220-8. PubMed ID: 19004053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients.
    Guggino G; Ciccia F; Di Liberto D; Lo Pizzo M; Ruscitti P; Cipriani P; Ferrante A; Sireci G; Dieli F; Fourniè JJ; Giacomelli R; Triolo G
    Clin Exp Immunol; 2016 Dec; 186(3):277-283. PubMed ID: 27543964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Th17 and Th22 cells in psoriatic arthritis and psoriasis.
    Benham H; Norris P; Goodall J; Wechalekar MD; FitzGerald O; Szentpetery A; Smith M; Thomas R; Gaston H
    Arthritis Res Ther; 2013 Sep; 15(5):R136. PubMed ID: 24286492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.